Dachaigh › Leukemia myeloid geur › South Carolina

Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an South Carolina

Tha 16 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann an South Carolina.

Bailtean ann an South Carolina

Teacsa sgrùdaidh oifigeil (Beurla)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AnMed Health Cancer Center, Anderson
Prisma Health Richland Hospital, Columbia
McLeod Regional Medical Center, Florence
agus 12 a bharrachd

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain

Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Prisma Health Cancer Institute - Easley, Easley
Prisma Health Cancer Institute - Butternut, Greenville
agus 4 a bharrachd

A’ fastadhÌre 2

Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
agus 5 a bharrachd

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
agus 5 a bharrachd

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Prisma Health Cancer Institute - Easley, Easley
Prisma Health Cancer Institute - Butternut, Greenville
agus 4 a bharrachd

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
agus 5 a bharrachd

A’ fastadhÌre 2

Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Medical University of South Carolina, Charleston
Prisma Health Richland Hospital, Columbia
BI-LO Charities Children's Cancer Center, Greenville

A’ fastadhÌre 3

6 Months – 21 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

MUSC Health University Medical Center, Charleston

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT04996875

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Bon Secours St. Francis Cancer Center, Greenville

A’ fastadhÌre 1/2

Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT04588922

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Medical University of South Carolina, Charleston
Prisma Health Richland Hospital, Columbia
BI-LO Charities Children's Cancer Center, Greenville

A’ fastadhÌre 1/2

Suas gu aois 22 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Prisma Health Richland Hospital, Columbia

A’ fastadhÌre 3

29 Days – 21 Years · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Prisma Health, Greenville

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Medical University of South Carolina, Charleston

A’ fastadhSgrùdadh amharc

Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Medical University of South Carolina, Charleston

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Ògmh 2026 · NCT02074839

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Hollings Cancer Center, Charleston

A’ fastadhÌre 2/3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Gibl 2026 · NCT04256317

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Medical University of South Carolina, Charleston

A’ fastadhÌre 1/2

Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT04988555

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.